Last Updated: November 9, 2026

Patent: 9,371,355

Summary for Patent: 9,371,355

Title:	Process for production of fibrinogen
Abstract:	The present invention relates to a method or process for the manufacture of a virus and prion save native fibrinogen concentrate of high purity and low amounts of fibrinopeptide A and fibronectin.
Inventor(s):	Petra Schulz, Rainer Pape, Werner Gehringer
Assignee:	Octapharma AG
Application Number:	US13/825,317
Patent Claims:	see list of patent claims

Details for Patent 9,371,355

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Csl Behring Gmbh	RIASTAP	fibrinogen concentrate (human)	For Injection	125317	January 16, 2009	⤷ Start Trial	2031-09-20
Csl Behring Gmbh	RIASTAP	fibrinogen concentrate (human)	For Injection	125317	December 19, 2025	⤷ Start Trial	2031-09-20
Octapharma Pharmazeutika Produktionsges.m.b.h.	OCTAPLAS	pooled plasma (human), solvent/detergent treated	For Injection	125416	January 17, 2013	⤷ Start Trial	2031-09-20
Octapharma Pharmazeutika Produktionsges.m.b.h.	FIBRYGA	fibrinogen (human)	For Injection	125612	June 7, 2017	⤷ Start Trial	2031-09-20
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 9,371,355

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Australia	2011304364	⤷ Start Trial
Brazil	112013006384	⤷ Start Trial
Canada	2809471	⤷ Start Trial
China	103328503	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.